Search results for: Innovation Policy Prize

The Impact of New Medicines in the NHS: 70 Years of Innovation

14 August 2018

…new medicines. Seven themes arose from the interviews relating to i) the value of innovation, ii) complementarity and spillovers, iii) substitution, iv) policy, v) evidence, vi) understanding, and vii) collaboration….

Economic Aspects of the Development of New Medicines

1 January 1981

…success of pharmaceutical innovation. On the one hand there has been the spirit of enterprise in the pharmaceutical industry, characterised by competition, innovation, flexibility and a willingness to invest huge…

Evaluating Medical Innovation: The Societal View

8 April 2010

…mandatory guidelines for evaluating medical innovation now encourage or require this narrower, budget-based payer perspective.  As a result, they argue, decisions often are suboptimal, for both health care and economies…

Activity Based Funding for Hospitals: English Policy, International Experience

1 October 2004

…research to help the policy achieve its objectives. The English Department of Health’s key policy objectives for ‘payment by results’ are set out by Bob Dredge in the first chapter…

Policy, Organisation and Incentives in Health Systems

Policy, Organisation and Incentives in Health Systems Development of effective health system policy requires an understanding of organisational structures, funding streams, and incentive mechanisms that shape how healthcare interventions and…

R&D for new drugs to tackle AMR is a high-return investment for all EU member states

19 July 2024

…also predict high returns from this policy, with benefit-cost ratios in the EU ranging from 1.3:1 to 4.6:1 over 10 years, and from 6.1:1 to 21:1 over 30 years. Previously,…

The CBO Doesn’t Understand Investors

13 September 2021

…innovation (i.e., the relationship between a reduction in revenue and outputs of innovation) to expected revenues based on estimates from the academic literature at an aggregate industry level. Our later…

Medical Research: How Long Does it Take?

10 February 2015

…take to bear fruit is surprisingly hard to use to inform research policy and practice. Different studies measure elapsed times between different points in the research history of an innovation….

Breaking the European Deadlock: Part 3 – Revenue Guarantee and Subscription Models for New Antibiotics

16 January 2024

…PMCID: PMC8234425.  Årdal et al., 2023. A Pan-EU/EEA Pull Incentive for Antimicrobial Innovation and Access. DRIVE-AB Policy Brief. Available at: https://drive-ab.eu/news/drive-ab-policy-brief-a-pan-eu-eea-pull-incentive-for-antimicrobial-innovation-and-access/  Brassel S., Firth I., Oliver E., Hampson, G., Towse A….